Progress in Rapid Identification of Variants Linked to Genetic Diseases

8 August 2016

Learn how DNA sequencing is leading to progress in the rapid identification of variants that might be involved in genetic diseases. Thanks to this work, Dr Kingsmore and his team now hold a Guinness World Records ® title. Learn more at: Products: TruSeq® sample preparation kit: Illumina HiSeq®: Illumina Human CytoSNP-12 BeadChip: Illumina Human 1M-Duo BeadChip: For Research Use Only. Not for use in diagnostic procedures. Publication Links: PMID: 25985138| Taylor, et al. (2015): PMID: 25985138| Willig, et al. (2015): PMID: 25985138| Miller, et al. (2015): The Science Mondays (SciMon) series is brought to you by Illumina Illumina hosts Irene Predazzi, Sr Scientific Liaison, of Scientific Affairs, and Jacques Retief, Associate Director of Scientific Affairs, give you a quick report on breaking news. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on